Puma Biotechnology
PBYI
#8422
Rank
NZ$0.20 B
Marketcap
$4.12
Share price
-1.16%
Change (1 day)
-6.05%
Change (1 year)

Operating Margin for Puma Biotechnology (PBYI)

Operating Margin as of September 2024 (TTM): 4.59%

According to Puma Biotechnology's latest financial reports and stock price the company's current Operating Margin is 4.59%. At the end of 2023 the company had an Operating Margin of 9.62%.

Operating Margin history for Puma Biotechnology from 2018 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
20239.62%4701.34%
20220.20%-101.76%
2021-11.38%-57.16%
2020-26.56%-4.28%
2019-27.75%-38.67%
2018-45.24%-95.71%
2017-1,054.56%

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.